MBC-11

• Description:

  MBC-11 is a first-in-class conjugate of the bone-targeting bisphosphonate etidronate covalently linked to the antimetabolite cytarabine (araC), with potential to treat tumor-induced bone disease (TIBD) .

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  511.21

• Molecular Formula:

  C11H20N3O14P3

• Notes:

  Research use only, not for human use.

• Receptor:

  Others

• CAS Number:

  332863-86-2